UPDATE 1-AstraZeneca pill slashes lung cancer progression in study By: Reuters: Company News December 06, 2016 at 04:52 AM EST * Drug targets genetic mutation common in China, east Asia (Adds AstraZeneca comment, further details) Read More >> Related Stocks: Astrazeneca Plc ADR